Spots Global Cancer Trial Database for Biomarker Guided Treatment in DLBCL
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Biomarker Guided Treatment in DLBCL
Official Title: A Randomized, Phase 2 Study of Biomarker Guided Treatment in DLBCL
Study ID: NCT04025593
Conditions
Diffuse Large B Cell Lymphoma
Study Description
Brief Summary: This study is to investigate the strategy of biomarker guided treatment in diffuse large B cell lymphoma
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Ruijin hospital, Shanghai, Shanghai, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
